![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
RETRACTION article
Front. Physiol. , 07 September 2023
Sec. Integrative Physiology
Volume 14 - 2023 | https://doi.org/10.3389/fphys.2023.1287303
This article is a retraction of:
RETRACTED: HOXC10 Promotes the Metastasis of Human Lung Adenocarcinoma and Indicates Poor Survival Outcome
A Retraction of the Original Research Article
HOXC10 promotes the metastasis of human lung adenocarcinoma and indicates poor survival outcome
by Tang X-L, Ding B-X, Hua Y, Chen H, Wu T, Chen Z-Q and Yuan C-H (2017). Front. Physiol. 8:557. doi: 10.3389/fphys.2017.00557
The journal retracts the 02 August 2017 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.
This retraction was approved by the Chief Editors of Frontiers in Physiology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.
Citation: Frontiers Editorial Office (2023) Retraction: HOXC10 promotes the metastasis of human lung adenocarcinoma and indicates poor survival outcome. Front. Physiol. 14:1287303. doi: 10.3389/fphys.2023.1287303
Received: 01 September 2023; Accepted: 04 September 2023;
Published: 07 September 2023.
Approved by:
Geoffrey A. Head, Baker Heart and Diabetes Institute, AustraliaCopyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.